Prof. Dr. Osamah J Saeedi obtained his Medical Doctorate from
the University of Texas–Southwestern. He is a Professor of Ophthalmology at the
University of Maryland School of Medicine in Baltimore, MD, and an Adjunct
Associate Professor of Bioengineering at the University of Maryland, College
Park. He completed ophthalmology residency at the University
of Texas–Southwestern Medical Center, and a glaucoma fellowship at the Wilmer
Eye Institute, Johns Hopkins University. He completed a Masters of Science in
Epidemiology and Clinical Research from the University of Maryland, Baltmore. He is the recipient of numerous awards including the NIH Director's Award, the Heidelberg Xtreme Research Award, and was recently recognized with a distinguished alumni award from the University of Maryland Graduate School. He has received funding from the National Institutes of Health as well as numerous other
organizations. His research focuses on
finding novel imaging biomarkers for glaucoma, specifically looking at novel techniques for assessing ocular blood flow.
Research Keywords & Expertise
Genetics
Glaucoma
Health Services Resear...
Ocular blood flow
Ophthalmic imaging
Fingerprints
61%
Glaucoma
5%
Genetics
Short Biography
Prof. Dr. Osamah J Saeedi obtained his Medical Doctorate from
the University of Texas–Southwestern. He is a Professor of Ophthalmology at the
University of Maryland School of Medicine in Baltimore, MD, and an Adjunct
Associate Professor of Bioengineering at the University of Maryland, College
Park. He completed ophthalmology residency at the University
of Texas–Southwestern Medical Center, and a glaucoma fellowship at the Wilmer
Eye Institute, Johns Hopkins University. He completed a Masters of Science in
Epidemiology and Clinical Research from the University of Maryland, Baltmore. He is the recipient of numerous awards including the NIH Director's Award, the Heidelberg Xtreme Research Award, and was recently recognized with a distinguished alumni award from the University of Maryland Graduate School. He has received funding from the National Institutes of Health as well as numerous other
organizations. His research focuses on
finding novel imaging biomarkers for glaucoma, specifically looking at novel techniques for assessing ocular blood flow.